Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $313,212 - $511,123
-1,387 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$221.9 - $484.47 $55,918 - $122,086
252 Added 22.2%
1,387 $534,000
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $147,447 - $266,702
1,135 New
1,135 $401,000
Q1 2021

Apr 28, 2021

SELL
$109.18 - $185.98 $122,609 - $208,855
-1,123 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $73,826 - $190,752
1,123 New
1,123 $117,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Regent Peak Wealth Advisors LLC Portfolio

Follow Regent Peak Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Peak Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Peak Wealth Advisors LLC with notifications on news.